Shan N - Search Results

1

Identification of HSPA8 as a candidate biomarker for endometrial carcinoma by using iTRAQ-based proteomic analysis.

Shan N, Zhou W, Zhang S, Zhang Y. Shan N, et al. Onco Targets Ther. 2016 Apr 13;9:2169-79. doi: 10.2147/OTT.S97983. eCollection 2016. Onco Targets Ther. 2016. PMID: 27110132 Free PMC article.

2

Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer.

Wang L, Zhou W, Li H, Yang H, Shan N. Wang L, et al. Among authors: shan n. Front Oncol. 2020 Aug 28;10:1468. doi: 10.3389/fonc.2020.01468. eCollection 2020. Front Oncol. 2020. PMID: 32983981 Free PMC article.

3

Four Surgical Strategies for the Treatment of Cesarean Scar Defect: A Systematic Review and Network Meta-analysis.

He Y, Zhong J, Zhou W, Zeng S, Li H, Yang H, Shan N. He Y, et al. Among authors: shan n. J Minim Invasive Gynecol. 2020 Mar-Apr;27(3):593-602. doi: 10.1016/j.jmig.2019.03.027. Epub 2019 Nov 5. J Minim Invasive Gynecol. 2020. PMID: 31698049

4

Cross-sectional and longitudinal associations between lipid accumulation product and hyperuricemia.

Zhou W, Shan N, Wei J, Zhou Y, Men M. Zhou W, et al. Among authors: shan n. Nutr Metab Cardiovasc Dis. 2022 Oct;32(10):2348-2355. doi: 10.1016/j.numecd.2022.06.022. Epub 2022 Jul 14. Nutr Metab Cardiovasc Dis. 2022. PMID: 35965249

5

Identification of significant genes signatures and prognostic biomarkers in cervical squamous carcinoma via bioinformatic data.

He Y, Hu S, Zhong J, Cheng A, Shan N. He Y, et al. Among authors: shan n. PeerJ. 2020 Dec 2;8:e10386. doi: 10.7717/peerj.10386. eCollection 2020. PeerJ. 2020. PMID: 33344075 Free PMC article.

6

Development and Validation of an RNA-Binding Protein-Based Prognostic Model for Ovarian Serous Cystadenocarcinoma.

He Y, Zeng S, Hu S, Zhang F, Shan N. He Y, et al. Among authors: shan n. Front Genet. 2020 Oct 15;11:584624. doi: 10.3389/fgene.2020.584624. eCollection 2020. Front Genet. 2020. PMID: 33193718 Free PMC article.

7

Anticancer role of MUC1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.

Dai F, Zhang Y, Zhu X, Shan N, Chen Y. Dai F, et al. Among authors: shan n. Target Oncol. 2012 Dec;7(4):217-25. doi: 10.1007/s11523-012-0236-7. Epub 2012 Nov 20. Target Oncol. 2012. PMID: 23179556

8

Clinical Characteristics Predict Recurrence in Borderline Ovarian Tumor Patients with Fertility-Preserving Surgery.

He Y, Zhong J, Yang H, Shan N, Cheng A. He Y, et al. Among authors: shan n. Int J Gen Med. 2022 Feb 26;15:2197-2206. doi: 10.2147/IJGM.S349451. eCollection 2022. Int J Gen Med. 2022. PMID: 35250297 Free PMC article.

9

The anti-chemoresistant effect and mechanism of MUC1 aptamer-miR-29b chimera in ovarian cancer.

Dai F, Zhang Y, Zhu X, Shan N, Chen Y. Dai F, et al. Among authors: shan n. Gynecol Oncol. 2013 Nov;131(2):451-9. doi: 10.1016/j.ygyno.2013.07.112. Epub 2013 Aug 8. Gynecol Oncol. 2013. PMID: 23933187

10

Clinical Implications of Breast Cancer Intrinsic Subtypes.

Rios-Hoyo A, Shan NL, Karn PL, Pusztai L. Rios-Hoyo A, et al. Among authors: shan nl. Adv Exp Med Biol. 2025;1464:435-448. doi: 10.1007/978-3-031-70875-6_21. Adv Exp Med Biol. 2025. PMID: 39821037 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

229 results

Search Page

Filters